Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Correction: Vitamin D and Risk of Multiple Sclerosis: A Mendelian Randomization Study.
Exergaming with additional postural demands improves balance and gait in patients with multiple sclerosis as much as conventional balance training and leads to high adherence to home-based balance training.
A method for estimating and removing streaking artifacts in quantitative susceptibility mapping.
IMMUNE SYSTEM INDUCTION OF NERVE GROWTH FACTOR IN AN ANIMAL MODEL OF MULTIPLE SCLEROSIS: IMPLICATIONS IN RE-MYELINATION AND MYELIN REPAIR.
Wallerian and trans-synaptic degeneration contribute to optic radiation damage in multiple sclerosis: a diffusion tensor MRI study.
Patients with neuromyelitis optica have a more severe disease than patients with relapsingremitting multiple sclerosis, including higher risk of dying of a demyelinating disease.
Multiple Sclerosis: Progress, but No Cure.
Acute Bilateral Optic Neuritis in Active Ankylosing Spondylitis.
Protease activated receptor-1 antagonist ameliorates the clinical symptoms of experimental autoimmune encephalomyelitis via inhibiting breakdown of blood brain barrier.
Apoptosis of Oligodendrocytes during Early Development Delays Myelination and Impairs Subsequent Responses to Demyelination.
Oligodendrocyte progenitor programming and reprogramming: Toward myelin regeneration.
Anxiety and Depressive Symptoms Are Associated With Worse Performance on Objective Cognitive Tests in MS.
Season of birth and multiple sclerosis in Tunisia.
[Oral disease-modifying agents in relapsing-remitting multiple sclerosis].
A Protocol for the Use of Remotely-Supervised Transcranial Direct Current Stimulation (tDCS) in Multiple Sclerosis (MS).
Epigallocatechin-3-gallate rescues LPS-impaired adult hippocampal neurogenesis through suppressing the TLR4-NF-κB signaling pathway in mice.
Brain reserve and cognitive reserve in multiple sclerosis: What you've got and how you use it.
Considerations for subgroups and phenocopies in complex disease genetics.
Mesenchymal stem cells (MSC) derived from mice with experimental autoimmune encephalomyelitis (EAE) suppress EAE and have similar biological properties with MSC from healthy donors.
Current and Future Therapies for Multiple Sclerosis.
[Locomotive syndrome and Frailty. Vitamin D and Frailty].
Regulatory T Cells in Central Nervous System Injury: A Double-Edged Sword.
Isoniazid in autoimmunity: a trigger for multiple sclerosis?
[Proportion and significance of CD1d(hi)CD5(+)CD19(+) regulatory B cell in peripheral blood of patients with neuromyelitis optica].
Repeatability of quantitative sodium magnetic resonance imaging for estimating pseudo-intracellular sodium concentration and pseudo-extracellular volume fraction in brain at 3 T.
Pages
« first
‹ previous
…
608
609
610
611
612
613
614
615
616
…
next ›
last »